95
Participants
Start Date
November 30, 2004
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
candesartan cilexetil (Atacand)
0.05 mg/kg once daily oral liquid dose
candesartan cilexetil (Atacand)
0.20 mg/kg once daily oral liquid dose
candesartan cilexetil (Atacand)
0.40 mg/kg once daily oral liquid dose
Research Site, Birmingham
Research Site, Little Rock
Research Site, Los Angeles
Research Site, San Francisco
Research Site, Miami
Research Site, Orlando
Research Site, Boise
Research Site, Detroit
Research Site, Durham
Research Site, Cleveland
Research Site, Portland
Research Site, Malvern
Research Site, Chattanooga
Research Site, Beaumont
Research Site, Houston
Research Site, San Antonio
Research Site, Edegem
Research Site, Ghent
Research Site, Aarhus
Research Site, Strasbourg
Research Site, Berlin
Research Site, Erlangen
Research Site, Hamburg
Research Site, Heidelberg
Research Site, Marburg
Research Site, Rostock
Research Site, Genova
Research Site, Milan
Research Site, Padua
Research Site, Roma
Research Site, Gdansk
Research Site, Krakow
Research Site, Warsaw
Research Site, San Juan
Research Site, Crimea
Research Site, Kyiv
Research Site, London
Research Site, Manchester
Lead Sponsor
AstraZeneca
INDUSTRY